1. Home
  2. GSAT vs CYTK Comparison

GSAT vs CYTK Comparison

Compare GSAT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$82.38

Market Cap

10.7B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$73.96

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSAT
CYTK
Founded
2003
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.7B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
GSAT
CYTK
Price
$82.38
$73.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
19
Target Price
$70.50
$89.26
AVG Volume (30 Days)
627.2K
1.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
74.58
N/A
EPS
N/A
N/A
Revenue
$112,660,000.00
$13,368,000.00
Revenue This Year
$10.31
$7.37
Revenue Next Year
$15.93
$310.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.36
$47.22
52 Week High
$84.85
$88.31

Technical Indicators

Market Signals
Indicator
GSAT
CYTK
Relative Strength Index (RSI) 49.18 45.18
Support Level $80.90 $73.34
Resistance Level $82.10 $79.73
Average True Range (ATR) 0.65 2.35
MACD -0.08 0.05
Stochastic Oscillator 47.88 43.07

Price Performance

Historical Comparison
GSAT
CYTK

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: